Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Musculoskeletal > Micro: Ryan/Whitt > Flashcards

Micro: Ryan/Whitt Flashcards

1
Q

parvovirus B19

A

FIFTH DISEASE
non-enveloped, ssDNA
S PHASE replication: RBC PRECURSORS
transmission: respiratory, percutaneous through blood, mother to fetus: vertical transmission

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

human herpes virus 6 & 7

A

ROSEOLA
enveloped, large dsDNA
complications due to long-term latent infection if become immunosuppression (STEM CELL TRANSPLANT recipients): brain, lung, heart, kidneys, GI; COGNITIVE DYSFUNCTION, permanent disability and death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

paramyxovirus

A

MEASLES, MUMPS

enveloped, large -ssRNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

togavirus

A

RUBELLA
enveloped, +ssRNA
Sx: mild, MORBILIFOM rash (maculopapular) on FACE that spreads to rest of body, low fever, conjunctivitis, sore throat, LAD
transmission: aerosol
isolate: stool, nasopharynx
viral shedding: continues after rash disappears
CONGENITAL BIRTH DEFECTS: 1st and 2nd trimester: retardation, motor disability, hearing loss, congenital heart disease, cataracts, BLUEBERRY MUFFIN rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

picronovirus (enteroviruses)

A

COXSACKIE A, ECHO, ENTEROVIRUSES
non-enveloped, +ssRNA
differentiate from rhinovirus: acid stability, less stringent growth requirement (human and primate cell lines, grows well at 37 C)
HUMANS only known reservoir
oral-fecal route, fomites
lymphoid replication: URT, tonsils, lymph nodes, Peyer’s patches, small intestine; followed by viremia and infects spinal cord, brain, meninges, myocardium, skin
isolated: throat culture

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Coxsackie A

A

HAND, FOOT, MOUTH DISEASE
HERPANGINA
Sx: asymptomatic is common
MENINGITIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ECHO

A

transient, non-descript rash

MENINGITIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Enteroviruses

A

asymptomatic, self limiting (Polio is exception)

seasonal: summer and fall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

measles

A

paromyxovirus: Morbilivirus genus
MV receptors: CD46, SLAM, NECTIN-4
H and F proteins (persistent CNS infection)
intracellular INCLUSION bodies
requires population greater than 100,000: under-vaccination, reservoir of susceptible individuals
respiratory route: extremely contagious
Sx: 10-14 days latent, HIGH FEVER, generalized RASH (T CELLS attack measles virus-infected vascular ENDOTHELIAL cells), COUGH, CORYZA, CONJUNCTIVITIS (PHOTOPHOBIA), MACULOPAPULAR RASH (cell mediated immune response and virus clearance); KOPLIK spots
mortality: bacterial pneumonia
MUST REPORT
LIFE-LONG immunity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Koplik spots

A

ONLY in measles
small abruption with blue-white centers in mouth
right before rash

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MIBE

A

measles inclusion body encephalitis

result from persistent MV infection in brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SSPE

A

subacute sclerosing panencephalitis

result from persistent infection in brain (years)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ADEM

A

acute disseminated encephalomyelitis
autoimmune demyelinating disease
against MYELIN BASIC PROTEIN
convulsions, deaf, retardation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

PIE

A

postinfectious encephalomyelitis
autoimmune demyelinating disease
against MYELIN BASIC PROTEIN
convulsions, deaf, retardation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

measles virus eradication

A

immunization: one serotype, clinical identifiable, no animal reservoir
requires HERD IMMUNITY
1963-67 vaccine not effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

MMR vaccine

A

mumps, measles, rubella
live, attenuated: life long immunity
SC
MMR at 12-15 months, 4-6 years 2nd dose; do not start before 6 months (mom Ab make vaccination incomplete)
vaccine effectiveness: ANTIGENICALLY STABLE MONOTYPIC VIRUSES
post exposure: MMR vaccine within 72 hrs of exposure or Ig within 6 days
only HUMANS have these viruses
CI: allergy to eggs, pregnancy, immunodeficient
MMRV (varicella): more AE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

complication of measles

A

IMMUNE SUPPRESSION for a month after onset of rash (type IV hypersensitivity suppressed: TB), production of Ab and cell-mediated antigens suppressed (monocyte infection)
neuro: ADEM, PIE, MIBE, SSPE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Coxsackie B

A

pleurodynia, myocarditis, pericarditis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Hand, Foot, and Mouth disease

A 
coxsackievirus A16, A6, enterovirus71
HERPANGIA, fever, , headache, sore throat, abdominal pain, vesicular lesions on hands and/or feet
isolate: lesions and feces
highly contagious
Tx: symptomatic
20
Q

herpangia

A

round erosions on tongue and soft palate

21
Q

roseola

A

HHV-6/7
6 months - 4 yrs
high fever, non-itchy rash that disappears, loose stools

22
Q

mumps

A

NO RASH
URT to lymph nodes
PAROTID swelling
complication (CNS): MENINGITIS, DEAF (cochlea infection), post-pubertal men TESTES swell: INFERTILITY (not as child)
virus shed 6 days before onset of disease

23
Q

fifth disease (erythema infectiosum)

A

PARVO B19
children: erythematous rash on chest and arms LACEY RASH, SLAPPED CHEEK (very pink cheeks)
adults: less rash, polyarthritis, flu-like
biphasic: lytic infectious phase (flu-like), then couple weeks non-infectious immunologic phase (IgG neutralizes virus, rash)
CYTOKINE: flu-like
CELL MEDIATED: rash
complication: transient APLASTIC CRISIS (sickle cell), chronic ANEMIA (immunocompromised); miscarriage, fetal anemia, hydrops fetalis (vertical transmission)

24
Q

huma papilloma virus (HPV)

A

small circular dsDNA, non-enveloped, icosahedral
benign tumor: full length, circular, extrachromosomal
malignant: integrate into chromosome, partial genome, lose E2 (activates E6/7)
doesn’t encode own DNA pol
Sx: warts, cervical/head/neck CA (non-permissive cells), infantile laryngeal papillomas, epidermodysplasia verruciformis
Dx: clinical, genotyping on inconclusive Pap smears in women over 30
Tx: warts spontaneously regress, Sx, cryoSx, corrosives; imiquimod cream
recurrence common

25
Q

permissive cells

A

HPV

lytic replication

26
Q

non-permissive cells

A

HPV
genome is replicated but no virus particles are produced
late structural genes not expressed: no capsid made
TRANSFORMATION

27
Q

wart morphogenesis

A

HPV
1. virus infection through break in skin
2. migrates to progenitor skin cells that are nonpermissive
cells migrate to surface and become keratinocytes and can now replicate episomally and produce late genes and virus packaging
3. can infect another area where break in skin is: mounds/satellite warts

28
Q

E2

A

HPV malignancy

suppresses E6 and E7

29
Q

E6

A

HPV malignancy

degrades p53

30
Q

E7

A

HPV malignancy
inactivates Rb protein
cell cycle control is lost

31
Q

Gardasil

A

vaccine
3 IM doses: age 11-26 years
HPV 6, 11, 16, 18 virus made in yeast
L1 capsid protein that assembles into pseudocapsids

32
Q

herpesvirus

A

linear, dsDNA, enveloped, icosahedral, glycoproteins (on infected cells and virus allowing fusion of infected cells with non-infected cells)
replicated and assembled in nucleus
epithelial cells, neuronal cells
lytic, latent (establishment, maintenance, reactivation lapse in cell mediated immunity but localized due to high Ab)
HSV-1, HSV-2, VZV

33
Q

HSV-1

A

SKIN: herpetic gingivostomatitis, herpes labialis, herpes gladiatorum (wrestler’s: saliva in scrape), herpetic whitlow (ungloved dentist)
OCULAR (keratitis, conjunctivitis, blepharitis), ENCEPHALITIS (neonate, immunocompromised)
latent: trigeminal
Dx: PCR, TZANCK SMEAR

34
Q

HSV-2

A

urogenital, meningitis (neonates, immunocompromised)
latent: sacral, lumbar
Dx: PCR, TZANCK SMEAR

35
Q

varicella-zoster virus (VZV)

A

primary infection: chicken pox (spread by aerosol), severe in adults (pneumonia)
need secondary viremia for rash
reactivated: PAIN, rash along thoracic dermatome or forehead, postherpetic neuralgia (pain after rash is gone)
latent: dorsal root
Dx: clinical, TZANCK SMEAR
vaccine: children, older adults

36
Q

lytic cycle of herpesvirus

A
  1. bind heparin sulfate on glycoproteins and fuse at PM
  2. moves to nucleus
  3. immediate early transcription: transcription factors (has own DNA pol)
    early transcription: replication (uses host genome)
    late transcription: structural
  4. translation in cytoplasm
  5. reintroduced into nucleus and packaged into capsid
  6. bud into cytoplasm, release from ER to golgi to acquire envelope, exocytosis
37
Q

LAT

A

HSV, not VZV
latency associated transcript
produces microRNAs: repress viral gene expression, prevent apoptosis, impair CD8 T cell function
allows virus to evade immune system, prevent lytic replication and apoptosis of infected neuron

38
Q

Tzanck smear

A

HSV

giant multinucleated cells

39
Q

poxviridae

A

large, complex, enveloped, linear sDNA
variola, vaccinia, cowpox, monkeypox
replicate in CYTOPLASM: produce own RNA/DNA pol and most proteins

40
Q

variola

A

SMALLPOX
minor and major form (more fatal)
Sx: rash
transmission: inhale, lesions from infected
secondary viremia: see rash
death due to toxic effects on vascular endothelium

41
Q

vaccinia

A

SMALLPOX vaccine
Hx: variolation, cowpox
LIVE vaccine to eradicate variola
localized lesion that heals in 2 weeks, wanes after 3 yrs, gone after 20 yrs
complications (can Tx some with cidofovir): severe rxn, life treating rxn, death due to encephalitis or shock or myocarditis/MI
effective: humans only reservoir, no healthy carriers, no sub-clinical infection, vaccine available
don’t get vaccine if: pregnant, breast feeding, immunodeficient, eczema, atopic dermatitis, under 18 unless emergency, heart disease

42
Q

monkeypox

A

deadly to humans

43
Q

molluscum contagiosum

A

poxvirus
child: lesions on face, trunk, lesions; spread through skin
adult: lesions on lower abdomen; STD
Dx: clinical, confirmed by cytoplasmic INCLUSIONS in keratinocytes
lesions disappear in 2-12 months

44
Q

drug rashes

A

most common: morbilliform
delayed (type IV) hypersensitivity: T cells
less common: urticaria, angioedema, anaphylaxis, vasculitis, photoallergic
life threatening rash: SJS, exfoliative dermatitis, DRESS (drug run with eosinophilia and systemic symptoms)
rare: bollous diseases, AGE (acute generalized pustular eruption), lupus, pseudo lymphoma, lichenoid
HLA genetic predisposition in some severe rxns

45
Q

leprosy (Hansen’s disease)

A

MYCOBACTERIUM LEPRAE: intracellular in macrophages and Schwann cells
INDIA, BRAZIL
chronic, granulomatous
peripheral nerves, superficial tissues (esp. nasal mucosa)
transmission: nasal secretions
only in humans and armadillos
low infectivity: req. prolonged close contact with infected
incubation: 2-7 yrs
depends on T cell mediated immunity: lepromatous cases lack TH1
can’t culture

46
Q

tuberculoid leprosy

A 
single skin lesions on face, limbs, butt
lesions can be anesthetic (face ones usually not)
low number of organism 
not contagious
heal spontaneously
prognosis: good
Tx 1 year: multidrug: sulfone, rifampin
47
Q

lepromatous leprosy

A

edema, rhinitis
extensive lesions: face, limbs, butt
severe: nasal perforation, collapse of nose, loss of fingers, atrophy of testes
ear lobe scrapings: recover acid fast bacilli
lack TH1, spread through reticuloendothelial system
Tx 2 years: multidrug: solfone, rifampin, clofazimine

Musculoskeletal (13 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions